Can Finerenone Alter Glomerular Disease Trajectory? - Top-Institutions - MDSpire

Can Finerenone Alter Glomerular Disease Trajectory?

  • By

  • Kathryn Wighton

  • June 5, 2026

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    The George Institute for Global Health
    The George Institute for Global Health

    Sydney, New South Wales

    Key Differentiators

    • Nephrology

  • #2

    University of New South Wales
    University of New South Wales

    Sydney, New South Wales

    Key Differentiators

    • Nephrology

  • #3

    University Medical Center Groningen
    University Medical Center Groningen

    Groningen, Groningen

    Key Differentiators

    • Nephrology

  • #4

    University of Glasgow
    University of Glasgow

    Glasgow, Scotland

    Key Differentiators

    • Nephrology

  • #5

    Osaka University Graduate School of Medicine
    Osaka University Graduate School of Medicine

    Osaka, Osaka

    Key Differentiators

    • Nephrology

Original Source(s)

Can Finerenone Alter Glomerular Disease Trajectory?

  • by Kathryn Wighton

  • June 5, 2026

Related Content

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Can Uric Acid Distinguish Lipedema From Overweight?

Metabolomics analysis identified higher uric acid levels in patients with lipedema and lymphedema, although associations weakened following adjustment for renal insufficiency.

Troponin Testing and Early MI Discharge

Sixth-generation high-sensitivity cardiac troponin T assay classifies more patients below a low-risk threshold at presentation.